Now Recruiting: Deputy Editors
Oxford University Press (OUP) invites applications for the position of Deputy Editor for The Oncologist. There are two Deputy Editor positions available, each
Related Articles
Complement-Mediated Kidney Disorders: A Case Series
Three case studies exploring complexities of diagnosing, treating, and managing patients with various complement-mediated kidney disorders.
Highlighting Insights From the Marginal Zone Lymphoma Workshop
Clinicians outline the significance of the MZL Workshop, where a gathering of international experts in the field discussed updates in the disease state.
CAR-T Meeting 2025 | VJHemOnc
Jointly organized by the EHA and EBMT, the 7th European CAR T-cell Meeting is taking place on February 6-8, 2025, in Strasbourg, France, and online,…
Radiation Plus Combination Immunotherapy May Help Preserve Bladder in Some Patients With Muscle-invasive Bladder Cancer
Radiation plus immunotherapy may help some patients with invasive bladder cancer keep their bladders, according to a study published in Clinical Cancer Research.
Trump administration caps indirect costs at 15%, inviting injunctions, congressional scrutiny The move could gut academic cancer research – The Cancer Letter
Late on Friday, Feb. 7, the Trump administration announced that indirect costs paid on grants to U.S. medical research institutions would—starting immediately—henceforth be capped at…
Lifestyle factors impact aspirin’s effect on colorectal cancer prevention
Individuals with unhealthy lifestyles may derive the most benefit from aspirin for colorectal cancer prevention, according to results of a prospective cohort study.Regular aspirin use…
Enfortumab Vedotin Plus Pembrolizumab vs. Chemotherapy for Untreated la/mUC: EV-302 Study Update
Dr. Thomas Powles, MBBS, MRCP, MD, from Barts Cancer Institute at Queen Mary University of Londonon February 17, 2025 At the 2025 ASCO Genitourinary Cancers…
Pegylated liposomal doxorubicin in partially platinum-sensitive, platinum-resistant, or platinum-refractory ovarian cancer: a prospective study
This study evaluated the efficacy and safety of pegylated liposomal doxorubicin for patients with partially platinum-sensitive, platinum-resistant, or plat
Investigators Look to Add Duvelisib to Treatment Arsenal of Rare T-Cell Lymphoma Subtype
Christopher P. Fox, PhD, discusses the upcoming phase 3 TERZO trial of duvelisib in patients with nodal T-cell lymphoma with follicular helper T phenotype.
APCCC Diagnostics 2025 – APCCC
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid…
